Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 5, 2021

View Archived Issues

Modulating PPM1E is a therapeutic approach in type 2 diabetes

Genentech patents new TEAD inhibitors

E-Scape Bio discloses LRRK2 inhibitors

University of Kentucky identifies histone demethylase and Wnt signaling inhibitors

Janpix divulges new STAT5 inhibitors

Fochon Pharmaceuticals synthesizes new BTK inhibitors

Microbiome therapy SER-155 may restore colonization resistance and prevent infection

JSF-3151 demonstrates efficacy in mouse model of MRSA infection

Selecta and Takeda enter strategic licensing agreement for lysosomal storage disorders

OncoTherapy Science presents data on OTSA-101 in cervical cancer mouse model

Targeting ADGRF1 for obesity and associated metabolic diseases

Protein mimetic amyloid inhibitor shows antitumor activity in vivo

KRP-A218, an oral PI4KB inhibitor, is a potent antiviral in vivo

Taysha collaborates with UTSW on next-generation construct for the treatment of CLN7 disease

New model provides insight into tau propagation in early Alzheimer's disease

Depression's doldrums linked to diagnostic duality at ECNP